FORMULARY CONVERSION OF CEFOXITIN USAGE TO CEFOTETAN - EXPERIENCE AT A LARGE TEACHING HOSPITAL

被引：11

作者：

SMITH, KS

BRICELAND, LL

NIGHTINGALE, CH

QUINTILIANI, R

机构：

[1] HARTFORD HOSP,DEPT PHARM SERV,HARTFORD,CT 06115

[2] HARTFORD HOSP,DEPT PHARM,HARTFORD,CT 06115

[3] HARTFORD HOSP,DIV INFECT DIS,HARTFORD,CT 06115

[4] UNIV CONNECTICUT,MED,STORRS,CT 06268

来源：

DICP-THE ANNALS OF PHARMACOTHERAPY | 1989年 / 23卷 / 12期

关键词：

D O I：

10.1177/106002808902301216

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1024 / 1030

页数：7

共 41 条

[11]

COX CE, 1983, 23RD INT C ANT AG CH, P228

[12] STATE REGULATORY POSITIONS CONCERNING THERAPEUTIC SUBSTITUTIONS IN HOSPITALS [J].

DOERING, PL ;

MCCORMICK, WC ;

KLAPP, DL ;

RUSSELL, WL .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (12) :1900-1903

[13] COAGULATION ABNORMALITIES INDUCED BY BETA-LACTAM ANTIBIOTICS IN CANCER-PATIENTS [J].

FAINSTEIN, V ;

BODEY, GP ;

MCCREDIE, KB ;

KEATING, MJ ;

ESTEY, EH ;

BOLIVAR, R ;

ELTING, L .

JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (04) :745-750

[14] ANALYSIS OF PROTHROMBIN TIME PROLONGATION IN NORTH-AMERICAN CEFOTETAN CLINICAL-TRIALS - QUESTIONS AND ANSWERS [J].

GOLDSTEIN, NH .

AMERICAN JOURNAL OF SURGERY, 1988, 155 (5A) :44-46

[15]

GRASELA TH, 1989, PHARMACOTHERAPY, V9, P158

[16] PHARMACOKINETICS OF SINGLE INTRAVENOUS AND INTRAMUSCULAR DOSES OF CEFOTETAN IN NORMAL HUMAN VOLUNTEERS [J].

GUIBERT, J ;

KITZIS, MD ;

YVELIN, C ;

ACAR, JF .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 :201-206

[17]

JOEHL RJ, 1983, ARCH SURG-CHICAGO, V118, P1259

[18]

KASPER DL, 1979, REV INFECT DIS, V1, P246

[19]

KASPER DL, 1979, REV INFECT DIS, V1, P278

[20]

KUCERS A, 1987, USE ANTIBIOTICS, P398

← 1 2 3 4 5 →